...
首页> 外文期刊>Current oncology >Linkage of clinical trial and administrative data: a survey of cancer patient preferences
【24h】

Linkage of clinical trial and administrative data: a survey of cancer patient preferences

机译:临床试验和行政数据之间的联系:癌症患者偏好调查

获取原文

摘要

Background Personal health information, including diagnoses and hospital admissions, is routinely collected in administrative databases. Patients enrolling on clinical trials consent to separate collection and storage of their personal health information. We evaluated patient preferences for linking long-term data from administrative databases with clinical trials. Methods Adults with cancer attending outpatient clinics at 3 Ontario hospitals were surveyed about their willingness, when faced with the hypothetical scenario of participating in a clinical trial, to provide potentially identifying information such as initials and date of birth to facilitate long-term research access to normally deidentified publicly collected databases. Results Of 569 patients surveyed, 335 (59%) were women, 452 (79%) were white, 385 (68%) had a post-secondary education, and 386 (68%) had never participated in a clinical trial. Median age in the group was 59 years. Most participants (93%, cohort 1) would allow long-term access to their information and allow personal information to be used to match clinical trial with administrative data. At the time of clinical trial closure, two thirds of participants (68%, cohort 2) preferred to make additional clinical information available through linkage with administrative databases, and 8 (9%) preferred to have no further information made available to researchers. No significant differences were found in the subset of patients who were part of a clinical trial and those who had never participated ( p = 0.65). Interpretation Almost all patients would allow a clinical trial research team to access their confidential information, providing a more comprehensive assessment of an intervention’s long-term risks and benefits.
机译:背景技术个人健康信息(包括诊断和住院情况)通常收集在管理数据库中。参加临床试验的患者同意分别收集和存储其个人健康信息。我们评估了患者的偏好,以便将行政数据库中的长期数据与临床试验联系起来。方法对在安大略省3所医院就诊的成人癌症患者进行调查,以了解他们是否愿意参加临床试验,以提供可能的识别信息,例如姓名缩写和出生日期,以方便长期研究通常取消身份识别的公开收集的数据库。结果在接受调查的569名患者中,女性335名(59%),白人452名(79%),大专学历的385名(68%),从未参加临床试验的386名(68%)。该组中位年龄为59岁。大多数参与者(93%,队列1)将允许长期访问其信息,并允许将个人信息用于将临床试验与管理数据进行匹配。在临床试验结束时,三分之二的参与者(68%,队列2)更愿意通过与管理数据库的链接获得更多的临床信息,而8(9%)的参与者更愿意不向研究人员提供更多信息。在参加临床试验的患者和从未参加过的患者中,没有发现显着差异(p = 0.65)。解释几乎所有患者都将允许临床试验研究小组访问其机密信息,从而对干预措施的长期风险和收益进行更全面的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号